There’s No Need To Panic Or Freeze When It Comes To ARS Pharmaceuticals Inc (NASDAQ: SPRY)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of ARS Pharmaceuticals Inc is $913.86M. A total of 0.72 million shares were traded on the day, compared to an average of 629.57K shares.

In the most recent transaction, RA CAPITAL MANAGEMENT, L.P. bought 505,954 shares of SPRY for 9.79 per share on Mar 27 ’24. After the transaction, the Director now owns 9,958,073 company shares. In a previous transaction on Mar 26 ’24, RA CAPITAL MANAGEMENT, L.P. bought 457,745 shares at 9.55 per share. SPRY shares that Director owns now total 9,452,119.

Among the insiders who bought shares, RA CAPITAL MANAGEMENT, L.P. acquired of 437,600 shares on Mar 25 ’24 at a per-share price of $9.06. This resulted in the Director holding 8,994,374 shares of SPRY after the transaction. In another insider transaction, Tanimoto Sarina sold 95,267 shares at $9.12 per share on Mar 25 ’24. Company shares held by the CHIEF MEDICAL OFFICER now total 1,697,447.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, SPRY has a high of $11.27 and a low of $2.55.

As of this writing, SPRY has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.08 per share and a lower estimate of -$0.14. The company reported an EPS of -$0.16 in the last quarter, which was 11.10% higher than expectations of -$0.18.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SPRY’s latest balance sheet shows that the firm has $60.06M in Cash & Short Term Investments as of fiscal 2021. There were $9.03M in debt and $8.19M in liabilities at the time. Its Book Value Per Share was $2.39, while its Total Shareholder’s Equity was -$31.27M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SPRY is Buy with a score of 5.00.

Most Popular

Related Posts